Avadel Pharmaceuticals plc. (AVDL) Stock Faltering After a Descent Friday
Avadel Pharmaceuticals plc. (AVDL), a biopharmaceutical company operating in the US, has declined 14.41% in aftermarket trading sessions and is changing hands at $8.55 at the time of writing. On Friday, AVDL closed the day at $9.99 after increasing 6.96% during the mid-day session. The increase came after the announcement of an ongoing FDA review […]
Avadel Pharmaceuticals plc. (AVDL) Stock Faltering After a Descent Friday Read More »